FDA Okays Alternative To Botox

But Agency Warns of Risks for Both Drugs

Discussion Policy
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
By Jodi Mailander Farrell
Miami Herald
Tuesday, May 26, 2009

The Food and Drug Administration has sanctioned a new wrinkle-remover, Dysport, for cosmetic and therapeutic use. Like Botox, it's an injectable drug derived from a botulinum toxin. It has been sold in Europe at a price cheaper than Botox for several years, and it is expected to be available in this country in 60 days.

Despite recent FDA warnings that these products could lead to poisoning, nearly 2.5 million Americans had Botox injections in 2008 for cosmetic reasons. Here's what you need to know before considering this treatment:

What is it? Injectable botulinum toxins are purified forms of the bacterial poison that causes botulism, a paralyzing disease that can be fatal. The drugs temporarily reduce or halt muscle activity.

Warnings: A day after approving Dysport, the FDA issued an order that Dysport and Botox must now carry the most stringent kind of warning labels. These alerts must explain that the material has the potential to spread from the injection site to distant parts of the body, with the risk of such serious difficulties as problems with swallowing or breathing. Requiring that a drug package carry a box with bold-face risk information -- a so-called black-box warning -- is one of the strongest safety actions the FDA can take. It's usually reserved for medications known to have serious or life-threatening risks, such as antidepressants.

Is it safe? The FDA began its safety review of botulinum-based products after being petitioned by the public advocacy group Public Citizen. The group says there have been 180 serious health problems and 16 deaths connected to the injections. But an FDA official in a news conference last month said the problems have occurred mainly in patients who received overdoses of the drug for unapproved treatments such as limb spasticity in children with cerebral palsy. Botulinum toxins are safe when administered for approved uses at approved doses, the FDA says.

Accepted uses: In the past 20 years, the FDA has approved Botox to treat crossed eyes, eyelid spasms, severe underarm sweating and cervical dystonia, a neck problem that can cause severe pain and abnormal head position. Under the name Botox Cosmetic, the drug is also approved to treat frown lines. The agency recently approved Dysport for frown lines and cervical dystonia.

More info: Read about the FDA's ongoing safety review at http://www.fda.gov/cder/drug/early_comm/botulinium_toxins200904.htm.



© 2009 The Washington Post Company